Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Pediatr Pulmonol ; 51(8): 803-11, 2016 08.
Artículo en Inglés | MEDLINE | ID: mdl-26797879

RESUMEN

RATIONALE: Maternal prepregnancy obesity has been associated with early wheeze and childhood asthma in their offspring. Some of these studies have been in minority, urban, and disadvantaged populations using parental recall and questionnaires. The association of maternal prepregnancy obesity with bronchodilator dispensing to their offspring, in a primarily insured, non-urban, White population in the United States is unknown. OBJECTIVES AND METHODS: We conducted a retrospective cohort study using pharmacy dispensing data from the electronic medical records of a large United States health maintenance organization to examine the relationship between maternal prepregnancy body mass index (BMI) and inhaled bronchodilator dispensing in the offspring to 4 years of age. We included infants ≥37 weeks' gestation with birth weight ≥2.5 kg which yielded 6,194 mother-baby pairs. Maternal prepregnancy BMI was categorized as underweight (<18.5 kg/m(2) ), normal (18.5-24.9 kg/m(2) ), overweight (25-29.9 kg/m(2) ), or obese (≥30 kg/m(2) ). RESULTS: In the entire cohort, 27.6% of the offspring received a bronchodilator dispensing. This ranged from 19.2% in the offspring of underweight mothers to 31.3% of those born to obese mothers. In the fully adjusted model using normal BMI as the referent, children of obese mothers had a 22% higher rate of bronchodilator dispensing (adjusted OR = 1.22; 95%CI 1.05-1.41; P = 0.008). CONCLUSIONS: In this insured, non-urban, White population, maternal prepregnancy obesity was associated with bronchodilator dispensing in the offspring in early life. These results extend previous data and reaffirm the potential widespread public health impact that prepregnancy obesity may have on subsequent childhood respiratory health. Pediatr Pulmonol. 2016;51:803-811. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Asma/tratamiento farmacológico , Índice de Masa Corporal , Broncodilatadores/uso terapéutico , Obesidad/complicaciones , Complicaciones del Embarazo , Adulto , Niño , Preescolar , Estudios Transversales , Femenino , Humanos , Lactante , Masculino , Obesidad/etnología , Sobrepeso/complicaciones , Sobrepeso/etnología , Embarazo , Estudios Retrospectivos , Delgadez/complicaciones , Delgadez/etnología , Estados Unidos , Población Blanca
2.
Health Informatics J ; 17(1): 72-88, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25133772

RESUMEN

The objective was to describe the utility of mixed methods to inform the development of an automated telephone intervention to improve patients' compliance with asthma medication. As part of intervention development for a larger trial, we conducted 15 focus groups (n = 53) to design and develop calls, and to identify factors influencing intervention acceptability and usefulness. We piloted four call types and interviewed 64 participants to further improve call content and receptivity to the intervention. Feedback led to several changes to the intervention scripts and eventual calls, and an initial pilot led us to drop one of the calls. During the pilot, we reached 43 percent of target participants; 74 percent of those stayed on the call until it ended. This process provided key insights about automated calls, and may have broader applicability for the development of automated interventions designed to help patients manage a variety of chronic conditions.


Asunto(s)
Asma/tratamiento farmacológico , Atención a la Salud/métodos , Cumplimiento de la Medicación , Aceptación de la Atención de Salud , Teléfono/estadística & datos numéricos , Grupos Focales , Humanos , Proyectos Piloto , Investigación Cualitativa , Sistemas Recordatorios
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA